Nutex Health (NASDAQ:NUTX) Posts Earnings Results, Beats Expectations By $4.63 EPS

Nutex Health (NASDAQ:NUTX) issued its earnings results on Thursday. The company reported $9.58 EPS for the quarter, topping the consensus estimate of $4.95 by $4.63, Zacks reports. Nutex Health had a return on equity of 23.50% and a net margin of 10.95%.

Nutex Health Price Performance

Shares of NASDAQ:NUTX traded down $5.33 during trading on Thursday, hitting $151.93. 180,920 shares of the company were exchanged, compared to its average volume of 113,827. Nutex Health has a 1-year low of $77.21 and a 1-year high of $204.00. The company has a market capitalization of $1.05 billion, a P/E ratio of 11.74 and a beta of 0.24. The company has a quick ratio of 3.12, a current ratio of 3.14 and a debt-to-equity ratio of 0.66. The business’s 50 day moving average is $156.57 and its 200-day moving average is $128.97.

Wall Street Analyst Weigh In

NUTX has been the subject of several research reports. Lake Street Capital assumed coverage on Nutex Health in a report on Tuesday, June 2nd. They set a “buy” rating and a $235.00 price target for the company. Zacks Research raised Nutex Health to a “hold” rating in a research report on Monday, June 29th. B. Riley Financial assumed coverage on Nutex Health in a research note on Friday, June 26th. They set a “buy” rating and a $290.00 target price on the stock. Weiss Ratings raised Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a report on Tuesday, July 28th. Finally, Wall Street Zen downgraded Nutex Health from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 20th. Three investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $243.33.

Institutional Trading of Nutex Health

Hedge funds have recently made changes to their positions in the company. Bank of America Corp DE increased its stake in shares of Nutex Health by 6,590.3% in the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock valued at $66,000 after buying an additional 2,043 shares during the period. Goldman Sachs Group Inc. lifted its position in shares of Nutex Health by 17.9% in the 1st quarter. Goldman Sachs Group Inc. now owns 18,119 shares of the company’s stock worth $852,000 after purchasing an additional 2,748 shares during the period. Jane Street Group LLC bought a new stake in shares of Nutex Health in the 1st quarter valued at $522,000. JPMorgan Chase & Co. grew its holdings in Nutex Health by 41,430.0% during the 2nd quarter. JPMorgan Chase & Co. now owns 8,306 shares of the company’s stock worth $1,034,000 after acquiring an additional 8,286 shares during the period. Finally, Legal & General Group Plc bought a new position in shares of Nutex Health in the 2nd quarter worth about $454,000. 5.32% of the stock is owned by institutional investors and hedge funds.

About Nutex Health

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.